Healthcare

Chimeric Therapeutics Limited (ASX:CHM) is a clinical-stage biotechnology company developing cell-based therapies for cancer. Its research includes chimeric antigen receptor T-cell (CAR-T) treatments and natural killer (NK) cell approaches. During 2026, the company reassessed its CDH17-focused clinical program following safety findings and outlined changes …

In its 12 October 2026 commercial update, EBR Systems, Inc. (ASX:EBR) reported 40 commercial WiSE implants for the September quarter, compared with 46 in the June quarter. The cumulative number of implants across its pilot phase and limited market release reached 157. September activity …

CLINUVEL PHARMACEUTICALS LTD (ASX:CUV) announced on 30 October 2026 that it has filed a dossier for marketing authorisation of its second pharmaceutical product, NEURACTHEL Instant. The filing was made with national European regulators through the decentralised procedure. The product is a branded generic formulation …

Doctor Care Anywhere Group PLC (ASX:DOC) released its unaudited trading update for the three months ended 30 September 2026 on 30 October 2026. The UK telehealth provider reported revenue growth of 16% to £11.3 million, with its weight management service contributing for the first …

ResMed Inc. (NYSE:RMD) reported results for the first quarter of fiscal 2027, covering the three months ended 30 September 2026. The sleep and breathing health company released its figures on 29 October 2026, showing revenue growth of 6% to about $1.4 billion. The results …

Vitasora Health Limited (ASX:VHL) announced on 30 October 2026 that it has secured a major new contract with a United States healthcare provider and entered into a working capital facility. The company, which also trades on the OTCQB market, said the contract sits alongside …

Ramsay Health Care Limited (ASX:RHC) operates private hospitals, clinics and surgical services in Australia, the United Kingdom and Europe. Its Australian business negotiates reimbursement rates with private health insurers for eligible hospital services, making contract indexation relevant to reported operating performance. FY26 disclosures discussed …